Gabapentin CAS: 60142-96-3

CAS NO: 60142-96-3
Gabapentin
Chemical Name: Gabapentin
Molecular Formula: C9H17NO2
Formula Weight: 171.24
CAS No.: 60142-96-3
Description Review
Description



Few substances in the pharmaceutical field have as wide a range of therapeutic applications as gabapentin. Gabapentin, also known by its chemical name 1-(aminomethyl)cyclohexaneacetic acid, is a structural analogue of the neurotransmitter gamma-aminobutyric acid (GABA) that is used to treat neuropathic pain and a number of neurological diseases.
Digital Impact: Gabapentin is frequently searched for on the internet, with significant search volumes devoted to phrases such as "Gabapentin neuropathic pain relief," "Gabapentin dosage," "Gabapentin side effects," "Gabapentin vs Pregabalin," "Gabapentin mechanism of action," and "Gabapentin anxiety treatment," which demonstrate the compound's versatile utility.
Industry Analysis:
Drugs like Pregabalin, Amitriptyline, and Duloxetine are often put next to gabapentin in a market that is very competitive. These options have comparable therapeutic advantages, yet they have different pharmacokinetic profiles and elicit different reactions from patients.


Scientific Discoveries:
The analgesic properties of gabapentin are the primary contributor to the drug's positive health effects. These effects are particularly useful in the treatment of neuropathic pain disorders, such as postherpetic neuralgia and diabetic neuropathy. Its flexibility earns it prescriptions for restless legs syndrome and migraine prevention.


Pharmacodynamics and Mechanism: The exact mechanism of gabapentin's action is unknown, however it is thought to include modulating voltage-gated calcium channels to decrease excitatory neurotransmitter release and neuropathic pain signals.


Safety Profile: Gabapentin has a noteworthy safety record and is often preferred over opioids because to its decreased risk for misuse and dependency. Additionally, the fact that it is not metabolized in the human body reduces the dangers associated with metabolic interactions.


Potential Side Effects: Gabapentin is safe, but it can cause some problems. The most often reported adverse responses were dizziness, somnolence, and peripheral edema. Alterations in mood or indicators of hypersensitivity are examples of more significant side effects, despite the fact that they are uncommon.

Instructions for Use: Efficacy and tolerability determine gabapentin dosage, which begins with a low dose and increases gradually. Given the variances in patient response and the therapeutic window, customized dosage is essential.


Important information to consider: Patients who have a history of hypersensitivity to gabapentin or its equivalents should avoid using it. Patients with renal impairment, in whom a dose adjustment is required to prevent accumulation, should exercise caution.


In summary: A breakthrough in pharmaceutical chemistry, gabapentin has brought relief to many suffering from neuropathic pain and other neurological disorders. Its complex mechanism of action, in conjunction with a comparatively high margin of safety, exemplifies the usefulness that it has in clinical medicine. Like with other drugs, the most effective use of this one is ensured by careful monitoring of its effects and a customized approach to dosage that maximizes therapeutic potential and minimizes negative effects. The story of gabapentin's transformation from chemical to medication is one of scientific innovation and therapeutic value.


Top ten keywords and synonyms from Google:

  1. Gabapentin side effects
  2. Gabapentin weight gain
  3. Gabapentin abuse
  4. Gabapentin dosage
  5. Gabapentin interactions
  6. Gabapentin high
  7. Gabapentin withdrawal
  8. Neurontin
  9. Anticonvulsant
  10. Pain relief

Some of the synonyms for gabapentin include:

  • Neurontin
  • Gralise
  • Horizant
  • Gabapentin enacarbil
  • Gabapentin hydrochloride
    1. Gabapentin for neuropathic pain,
    2. Gabapentin anticonvulsant properties,
    3. Gabapentin and GABA neurotransmitter,
    4. Gabapentin for epilepsy treatment,
    5. Gabapentin and restless leg syndrome,
    6. Gabapentin α2δ subunit binding,
    7. Gabapentin in central nervous system,
    8. Gabapentin and excitatory neurotransmitters,
    9. Gabapentin for neuronal excitability,
    10. Gabapentin synthetic GABA analogue.
      • Gabapentin uses,
      • Gabapentin mechanism of action,
      • Gabapentin and epilepsy,
      • Neuropathic pain treatment,
      • Restless leg syndrome therapy,
      • Gabapentin and GABA,
      • Voltage-gated calcium channels,
      • Neurological drug therapies,
      • Gabapentin side effects,
      • Gabapentin effectiveness.
    11.  
  •  

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code